and its subsidiary for Quarter 2 of 2019 ending on 30 June 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for
% as compared to the same period of last year. The increase of net profit was mainly in respond to the product mix and other income during the period as compared. In additional, the impacts derived from
29.1 Finance costs 250.93 403.07 (152.14) (37.7) Income tax expense 215.17 164.03 51.14 31.2 Total expenses 2,211.89 2,102.74 109.15 5.2 2,175.99 2,309.70 (133.71) (5.8) Non-controlling Interests - (3.04
51% 405 599 48% Cost of sales (68) (111) 63% (132) (210) 59% Gross Profit 138 201 46% 273 389 42% Other Income 3 3 0% 5 5 0% Selling and distribution expenses (68) (85) 25% (134) (160) 19
follow: Income statements Second Quarterly Operational Performance The Company reported Revenues from Hospital Operations of Baht 213.42 million, a 50.09% increase year-over-year from Baht 142.19 million
Baht 37.3 million. 4. Accrued income tax payable decreased Baht 1.7 million. 5. Long-term loans from financial institutions increased Baht 1,797.0 million. 6. Employee benefit obligations increased Baht
statements of profit or loss and other comprehensive income, the changes are as follows: - 1) The commission paid to obtain a customer contract shall be recorded as an asset and amortized to expenses on a
manufacture and 3rd party’s products for distribution prove their successfulness in generating incremental sales and gross profits to the Group, creating stable income sources with growth potential and
overdrawn amount 31 MB and settle the long-term loan to the financial institute in 1 year decreased 2 MB and increasing 4 MB from Income Tax Payable, decreased of the other liabilities 1 MB Shareholders
customers decreased Baht 41.7 million. 4. Accrued income tax payable decreased Baht 26.6 million. 5. Long-term loans from financial institutions increased Baht 1,023.9 million. 6. Employee benefit obligations